Your browser doesn't support javascript.
loading
Anti-PD-1 antibody treatment for melanoma - Authors' reply.
Beaver, Julia A; Keegan, Patricia; Lemery, Steven; Pazdur, Richard; Theoret, Marc R.
Afiliação
  • Beaver JA; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: julia.beaver@fda.hhs.gov.
  • Keegan P; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Lemery S; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Pazdur R; Oncology Center for Excellence, US Food and Drug Administration, Silver Spring, MD 20993, USA.
  • Theoret MR; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Lancet Oncol ; 19(5): e220, 2018 05.
Article em En | MEDLINE | ID: mdl-29726379
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article